Get the full picture
Sign in to uncover key details.
MapLight
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
800 Chesapeake Dr, Redwood City, Califor...Phone Number
(617) 984-6300Website
www.maplightrx.comRevenue
-Stock Symbol
MPLTIndustry
About MapLight
MapLight Therapeutics is a Redwood City, California-based clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its proprietary discovery platform combines optogenetics, spatial transcriptomics, and circuit-mapping technologies to identify disease-linked neural circuits. The company’s pipeline targets schizophrenia, Alzheimer’s disease psychosis, autism spectrum disorder, and Parkinson’s disease, with lead candidate ML-007C-MA in Phase 2 trials. MapLight completed its IPO and trades on the Nasdaq Global Market.Explore more
MapLight Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to MapLight
Compare insights from companies similar to MapLight, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
MapLight Tech Stack
A closer look at the technologies used by MapLight
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MapLight
Sign Up For FreeTo access detailed company insights
MapLight Therapeutics is a Redwood City, California-based clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its proprietary discovery platform combines optogenetics, spatial transcriptomics, and circuit-mapping technologies to identify disease-linked neural circuits. The company’s pipeli... Read More
